Article: Nicotinamide Riboside Supplementation Is Safe and Well-Tolerated in Heart Failure Patients: Clinical Findings

Cardiovascular Disease Cardiovascular Health Clinical Inflammation

Nicotinamide Riboside Supplementation Is Safe and Well-Tolerated in Heart Failure Patients: Clinical Findings

Objectives

To assess the safety and tolerability of NR in patients with Stage C heart failure with reduced ejection fraction (HFrEF).

Journal

JACC: Basic to Translational Science

Key Outcomes

High-dose NR supplementation was safe and well-tolerated, significantly, and dose-dependently (nearly) doubled whole blood NAD+ levels, and increased peripheral blood mononuclear cell (PBMC) mitochondrial respiration.
NR also decreased expression of inflammatory markers, such as NLRP3.

Duration

12 weeks

Dose

2000 mg

Study Design

Randomized, double-blind, placebo-controlled study in 30 patients with Stage C heart failure with reduced ejection fraction (HFrEF)

See Published Study

Clinical

Nicotinamide Riboside Supplementation Benefits in Early Parkinson's Disease: Clinical Findings

Objectives To assess the safety, tolerability, and cerebral penetration of NR therapy in Parkinson's disease (PD) patients, as well as determine if NR has an impact on their neurometabolic profile...